{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:40:34Z","timestamp":1793054434879,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijmmb.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T23:26:16Z","timestamp":1616801176000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 \u2013a systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Anirban Hom","family":"Choudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Duggal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvna","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha Sarathi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2021.03.002_bib1","article-title":"Therapeutic use of chloroquine andhydroxychloroquine in COVID-19 and other viral infections- a narrative review","volume":"35","author":"Hashem","year":"2020","journal-title":"T\u00a0ravel Med Infect Dis"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106028","article-title":"A\u00a0review on possible modes of action of chloroquine\/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic","author":"Tripathy","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104904","article-title":"The possible mechanisms of action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): a role for iron homeostasis?","volume":"158","author":"Quiros Roldan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS corona virus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3947\/ic.2015.47.3.212","article-title":"Rapid response team. Antiviral treatment guidelines for Middle East respiratory Syndrome","volume":"47","author":"Chong","year":"2015","journal-title":"Infect Chemother"},{"issue":"20","key":"10.1016\/j.ijmmb.2021.03.002_bib6","article-title":"Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review","author":"Rodrigo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1756-185X.13842","article-title":"A\u00a0systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)","volume":"23","author":"Shah","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jclinepi.2018.01.004","article-title":"Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age","volume":"97","author":"Page","year":"2018","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib9","doi-asserted-by":"crossref","first-page":"m1844","DOI":"10.1136\/bmj.m1844","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","volume":"369","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib10","doi-asserted-by":"crossref","unstructured":"Rosenberg ES, Dufort EM, Udo T et\u00a0al. Association of treatment with hydroxychloroquine or azithromycinwith in-hospital mortality in patients with COVID-19 in NewYork state. J. Am. Med. Assoc.. doi:10.1001\/jama.2020.8630.","DOI":"10.1001\/jama.2020.8630"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib11","article-title":"Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study","author":"Barbosa","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19","volume":"383","author":"Cavalcanti Ab","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib13","series-title":"Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19","author":"Geleris","year":"2020"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib14","unstructured":"Paccoud O, Tubach F,Baptiste A et\u00a0al. Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients with Mild to Severe Covid-19 in a French University Hospital."},{"issue":"10","key":"10.1016\/j.ijmmb.2021.03.002_bib15","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11427-020-1732-2","article-title":"Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19","volume":"63","author":"Yu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19","volume":"97","author":"Arshad","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101791","article-title":"Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine\/azithromycin and other regimens in Marseille, France: a retrospective analysis","volume":"36","author":"Lagier","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib18","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.ijmmb.2021.03.002_bib19","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial","volume":"173","author":"Caleb","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib20","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six lay follow up: a pilot observational study","volume":"34","author":"Gautreta","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS CoV2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib23","doi-asserted-by":"crossref","unstructured":"Hoffmann M., Kleine-Weber H., Kr\u00fcger N., M\u00fcller M., Drosten C., P\u00f6hlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 2020:2020. 01.31.929042.","DOI":"10.1101\/2020.01.31.929042"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.05.016","article-title":"Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review","author":"Rodrigo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.ijmmb.2021.03.002_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40261-020-00927-1","article-title":"An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19)","volume":"40","author":"Das","year":"2020","journal-title":"Clin. Drug Invest."},{"issue":"6","key":"10.1016\/j.ijmmb.2021.03.002_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/acem.14005","article-title":"A\u00a0rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19","volume":"27","author":"Chowdhury","year":"2020","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.ijmmb.2021.03.002_bib27","series-title":"Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial. medRxiv","author":"Chen","year":"2020"},{"issue":"20","key":"10.1016\/j.ijmmb.2021.03.002_bib28","first-page":"31180","article-title":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","volume":"S0140\u20136736","author":"Retracted","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijmmb.2021.03.002_bib29","unstructured":"CLINICAL MANAGEMENT PROTOCOL: COVID-19. Ministry of Health and Family Welfare Directorate General of Health Services (EMR Division), Government of India. Version 5."}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:18:50Z","timestamp":1759346330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0255085721000323"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.03.002","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 \u2013a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}